LifeStance Health Group, Inc. 8-K

What Happened
LifeStance Health Group, Inc. (LFST) announced an underwritten offering of 35,000,000 shares of its common stock that closed on May 12, 2026. All shares were sold by existing selling stockholders to J.P. Morgan Securities LLC as underwriter. Pursuant to the underwriting agreement, LifeStance agreed to buy 6,000,000 of those shares from the underwriter at the same price the underwriter paid the selling stockholders. The company did not receive any proceeds from the offering.

Key Details

• Offering size: 35,000,000 shares of common stock (all sold by selling stockholders).
• Company repurchase: LifeStance purchased 6,000,000 of the offered shares from the underwriter at the same per-share price paid by the underwriter.
• Closing date: May 12, 2026.
• Underwriter and counsel: J.P. Morgan Securities LLC served as underwriter; Ropes & Gray LLP provided a legal opinion filed as Exhibit 5.1.

Why It Matters
This filing documents a secondary sale by current shareholders rather than a capital raise for the company—LifeStance did not receive proceeds from the transaction. The company’s repurchase of 6 million shares could affect its outstanding share count or treasury holdings (as reflected in future filings), and may influence per-share metrics. Investors should watch subsequent disclosures (e.g., amendments to outstanding share counts or treasury stock accounting) and consider the transaction when assessing ownership changes and potential impacts on liquidity or share supply.